… fixed-dose combinations (FDCs) are reported in Table 1. The bronchorelaxant effect of
long-acting bronchodilator … However, the differences in bronchodilation between first dose and …

… the fixed-dose combination were more likely to exceed the threshold for clinically significant
SGRQ improvement than those receiving placebo or glycopyrrolate only. Numerical trends …

… Despite dual bronchodilation therapy still represents the cornerstone therapy for most … -acting
muscarinic antagonist (LAMA) fixed-dose combinations (FDCs). Considering the change …

… of the available inhaled LABA/LAMA fixed-dose combinations (FDCs) for the treatment of …
selection of the optimal bronchodilation therapy with LABA/LAMA FDCs for COPD patients. …

… Other long-acting bronchodilator drugs including mixed PDE3/4 inhibitors (Citation12); …
fixed dose combinations offer an advantage of either bronchodilator alone or in combinations, …

… combination bronchodilator therapies. Real world evidence for the benefits of combination
… (LABA) or dual therapy (DT) with a LAMA/LABA fixed dose combination (FDC) between …

… As such, combining exercise training (to improve limb muscle fatigue) with double
bronchodilation may produce superior results in terms of exercise tolerance for COPD patients. …

… seems to play an important role in optimizing bronchodilation. Several once-daily and
twice-daily LABA/LAMA FDCs have been developed or are in clinical development. LAMA/ICS …

… Individuals who initiate on a dual bronchodilator therapy are less likely to switch therapy
compared to individuals who initiate on a monotherapy bronchodilator. Participants in the dual …

… A fixed-dose combination (FDC) of the short-acting agents … Additionally, dual bronchodilation
with ipratropium and albuterol … the optimal dosing for olodaterol added to a fixed dose of …